BxPC-3-Derived Small Extracellular Vesicles Induce FOXP3+ Treg through ATM-AMPK-Sirtuins-Mediated FOXOs Nuclear Translocations

BxPC-3-Derived Small Extracellular Vesicles Induce FOXP3+ Treg through ATM-AMPK-Sirtuins-Mediated FOXOs Nuclear Translocations
复制标题

BxPC-3 衍生的小细胞外囊泡通过 ATM-AMPK-Sirtuins 介导的 FOXO 核易位诱导 FOXP3 Treg

DOI:
10.1016/j.isci.2020.101431
复制
发表时间:
2020-08
期刊:
影响因子:
5.8
通讯作者:
Cao Liping
Cao Liping
中科院分区:
综合性期刊2区
文献类型:
--
作者:
Shen Tao;Jia Shengnan;Ding Guoping;Ping Dongnan;Zhou Liangjing;Zhou Senhao;Cao Liping

文献摘要

参考文献

相似文献

胰腺导管腺癌(PDAC)的免疫治疗面临着严峻的挑战,特别是由于免疫原性差。癌细胞衍生的小细胞外囊泡(sEV)在损害免疫系统中起重要作用。然而,胰腺癌来源的sEV对T淋巴细胞的影响尚不清楚。在这里,我们研究了sEV处理的T淋巴细胞的表型和信号转导通路的变化。我们通过CyTOF鉴定了免疫检查点蛋白PD-1、PD-L1、CTLA 4和Tim-3的过表达以及sEV处理的T淋巴细胞中FOXP 3 + Treg簇的富集。基因组富集分析表明,sEV诱导的THBV-DNA损伤反应和代谢途径可能参与了THBV-DNA损伤。ATM、AMPK、SIRT 1、SIRT 2和SIRT 6在sEV处理的T淋巴细胞中依次激活,并且对于sEV上调FOXO 1A、FOXO 3A和FOXP 3的表达至关重要。我们的研究揭示了胰腺癌细胞来源的sEV对T淋巴细胞的影响和机制,并可能为开发PDAC治疗的免疫治疗策略提供见解。
Immunotherapy in pancreatic ductal adenocarcinoma (PDAC) treatment faces serious challenges, due particularly to the poor immunogenicity. Cancer cell-derived small extracellular vesicles (sEVs) play important roles in damaging the immune system. However, the effects of pancreatic cancer-derived sEVs on T lymphocytes are unknown. Here we investigated changes in phenotypes and signal transduction pathways in sEVs-treated T lymphocytes. We identified the overexpression of immune checkpoint proteins PD-1, PD-L1, CTLA4, and Tim-3 and the enrichment of FOXP3+ Treg cluster in sEVs-treated T lymphocytes by CyTOF. Gene set enrichment analysis revealed that DNA damage response and metabolic pathways might be involved in sEVs-induced Tregs. ATM, AMPK, SIRT1, SIRT2, and SIRT6 were activated sequentially in sEVs-treated T lymphocytes and essential for sEVs-upregulated expressions of FOXO1A, FOXO3A, and FOXP3. Our study reveals the impact and mechanism of pancreatic cancer cell-derived sEVs on T lymphocytes and may provide insights into developing immunotherapy strategies for PDAC treatment.
DOI: 10.1146/annurev.pathol.3.121806.154305
发表时间: 2021-08
期刊: Annual review of pathology
影响因子: --
作者:
A. Maitra;R. Hruban
通讯作者: A. Maitra;R. Hruban
DOI: 10.1002/0470871628.ch6
发表时间: 2003
影响因子: --
作者:
C. Baecher-Allan;Julia A. Brown;G. Freeman;D. Hafler
通讯作者: C. Baecher-Allan;Julia A. Brown;G. Freeman;D. Hafler
DOI: 10.1371/journal.pone.0160431
发表时间: 2016
期刊: PloS one
影响因子: 3.7
作者:
Wang X;Buechler NL;Martin A;Wells J;Yoza B;McCall CE;Vachharajani V
通讯作者: Vachharajani V
DOI: 10.3390/ijms21197307
发表时间: 2020-10-03
影响因子: 5.6
作者:
Huber M;Brehm CU;Gress TM;Buchholz M;Alashkar Alhamwe B;von Strandmann EP;Slater EP;Bartsch JW;Bauer C;Lauth M
通讯作者: Lauth M
DOI: 10.1093/annonc/mds224
发表时间: 2012-10-01
期刊: ANNALS OF ONCOLOGY
影响因子: 50.5
作者:
Seufferlein, T.;Bachet, J. B.;Rougier, P.
通讯作者: Rougier, P.